These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25358811)

  • 1. Spinal involvement in mucopolysaccharidoses: a review.
    Leone A; Rigante D; Amato DZ; Casale R; Pedone L; Magarelli N; Colosimo C
    Childs Nerv Syst; 2015 Feb; 31(2):203-12. PubMed ID: 25358811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic and neuroradiologic findings in the mucopolysaccharidoses.
    Lachman R; Martin KW; Castro S; Basto MA; Adams A; Teles EL
    J Pediatr Rehabil Med; 2010; 3(2):109-18. PubMed ID: 21791838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Management of Spinal Disorders in People with Mucopolysaccharidoses.
    Terai H; Nakamura H
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.
    Peck SH; Casal ML; Malhotra NR; Ficicioglu C; Smith LJ
    Mol Genet Metab; 2016 Aug; 118(4):232-43. PubMed ID: 27296532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.
    Solanki GA; Martin KW; Theroux MC; Lampe C; White KK; Shediac R; Lampe CG; Beck M; Mackenzie WG; Hendriksz CJ; Harmatz PR
    J Inherit Metab Dis; 2013 Mar; 36(2):339-55. PubMed ID: 23385297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniovertebral junction pathological features and their management in the mucopolysaccharidoses.
    Sganzerla EP; Giussani C; Grimaldi M; Parini R; Ingelmo P; Trezza A; Visocchi M
    Adv Tech Stand Neurosurg; 2014; 40():313-31. PubMed ID: 24265052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know.
    Reichert R; Campos LG; Vairo F; de Souza CF; Pérez JA; Duarte JÁ; Leiria FA; Anés M; Vedolin LM
    Radiographics; 2016; 36(5):1448-62. PubMed ID: 27618324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).
    Wald SL; Schmidek HH
    Neurosurgery; 1984 Jan; 14(1):83-8. PubMed ID: 6420724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurologic manifestations in mucopolysaccharidoses].
    Héron B
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S14-21. PubMed ID: 25063379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip disease in Mucopolysaccharidoses and Mucolipidoses: A review of mechanisms, interventions and future perspectives.
    Oussoren E; Wagenmakers MAEM; Link B; van der Meijden JC; Pijnappel WWMP; Ruijter GJG; Langeveld M; van der Ploeg AT
    Bone; 2021 Feb; 143():115729. PubMed ID: 33130340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory manifestations in mucopolysaccharidoses.
    Muhlebach MS; Wooten W; Muenzer J
    Paediatr Respir Rev; 2011 Jun; 12(2):133-8. PubMed ID: 21458742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.
    Boffi L; Russo P; Limongelli G
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):122. PubMed ID: 30442163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of the mucopolysaccharidoses.
    Lehman TJ; Miller N; Norquist B; Underhill L; Keutzer J
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v41-8. PubMed ID: 22210670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hearing loss and airway problems in children with mucopolysaccharidoses].
    Santos S; López L; González L; Domínguez MJ
    Acta Otorrinolaringol Esp; 2011; 62(6):411-7. PubMed ID: 21757178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular features in mucopolysaccharidosis: diagnosis and treatment.
    Del Longo A; Piozzi E; Schweizer F
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):125. PubMed ID: 30442167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy in mucopolysaccharidosis disorders.
    Scarpa M; Lourenço CM; Amartino H
    Mol Genet Metab; 2017 Dec; 122S():55-61. PubMed ID: 29170080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses.
    Boor R; Miebach E; Brühl K; Beck M
    Neuropediatrics; 2000 Jun; 31(3):122-7. PubMed ID: 10963098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique medical issues in adult patients with mucopolysaccharidoses.
    Mitchell J; Berger KI; Borgo A; Braunlin EA; Burton BK; Ghotme KA; Kircher SG; Molter D; Orchard PJ; Palmer J; Pastores GM; Rapoport DM; Wang RY; White K
    Eur J Intern Med; 2016 Oct; 34():2-10. PubMed ID: 27296591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.